This is the latest installment in a new series where BioPharma Dive uses data visualization to recap...
Treatment Innovations
In the rapidly evolving landscape of medical technology, a significant breakthrough has emerged in the fight against...
For decades, the standard workflow in preclinical toxicology remained stubbornly static: a pathologist would peer through a...
By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...
In a landmark development for pediatric neurology, Argus Cognitive has secured US Food and Drug Administration (FDA)...
The landscape of preclinical drug discovery is undergoing a profound metamorphosis. For decades, the life cycle of...
By Jonathan Gardner | Published October 8, 2026 In a move signaling a renewed focus on high-value,...
In the landscape of modern drug discovery, a quiet revolution is unfolding within the archives of pathology...
The Fall of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis
The Fall of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis
In a stark reminder of the volatile nature of the biotechnology sector, Caribou Biosciences—a CRISPR-focused firm co-founded...
In a landmark development for neurovascular medicine, California-based Sonorous Neurovascular has secured Investigational Device Exemption (IDE) approval...
